You just read:

RuiYi Announces the First Human Dosing of a Novel Antibody, Gerilimzumab, for the Treatment of Rheumatoid Arthritis and other Autoimmune Disorders

News provided by

RuiYi Inc.

Sep 22, 2015, 07:00 ET